US Patent Issued to Hoffmann-La Roche on Sept. 23 for "Hydropyrazino[1,2-d[1,4diazepine compounds for the treatment of autoimmune disease" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,240, issued on Sept. 23, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.).

"Hydropyrazino[1,2-d[1,4diazepine compounds for the treatment of autoimmune disease" was invented by Hongtao Xu (Shanghai), Zhisen Zhang (Shanghai), Wei Zhu (Shanghai) and Ge Zou (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of formula (I), wherein R1 and R3 and n are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds."

The patent was filed on Oct. 29, 2020, under Application No. 17/772,930.

*For further informat...